Floatz logo

Therapeutic Asset Ratings

637 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Irinotecan
Recurrent Colon Cancer
Fudan UniversityP3BBB (76)
Irinotecan
Stage IV Rectal Cancer
Fudan UniversityP2BBB (74)
Eloxatin
Liver Metastasis Colon Cancer
Fudan UniversityP4BBB (73)
Cytosin-Arabinosid
Leptomeningeal Metastases
Fudan UniversityP4BBB (72)
Vinorelbine
Recurrent Breast Carcinoma
Fudan UniversityP3BBB (72)
Metformin
Mild Cognitive Impairment
Fudan UniversityP4BB (70)
DEXAMETHASONE
Colorectal Adenocarcinoma Metastatic to the Liver
Fudan UniversityP3BB (70)
Epirubicin
Hepatocellular Carcinoma
Fudan UniversityP4BB (69)
ERIBULIN MONOMETHANESULFONATE
Breast Neoplasms
Fudan UniversityP4BB (69)
ROPIVACAINE
Anesthesia, Local
Fudan UniversityP4BB (69)
Carboplatin
HR+/HER2- Breast Cancer
Fudan UniversityP3BB (68)
Cetuximab
Recurrent Rectal Cancer
Fudan UniversityP3BB (68)
Famitinib
Triple-Negative Breast Cancer
Fudan UniversityP3BB (68)
Pembrolizumab
Hepatocellular Carcinoma
Fudan UniversityP3BB (68)
Raltitrexed
Hepatocellular Carcinoma
Fudan UniversityP3BB (68)
Shr-1701
Non-Small-Cell Lung Cancer
Fudan UniversityP3BB (68)
Vinorelbine
HER2-positive Breast Cancer
Fudan UniversityP3BB (68)
Carboplatin
Ovarian Cancer
Fudan UniversityP4BB (67)
Cetuximab
Colorectal Cancer
Fudan UniversityP4BB (67)
Cyclophosphamide
Breast Cancer
Fudan UniversityP4BB (67)
Docetaxel
Breast Cancer
Fudan UniversityP4BB (67)
LEUPROLIDE
Breast Cancer
Fudan UniversityP4BB (67)
ROPIVACAINE
Breast Neoplasms
Fudan UniversityP4BB (67)
Tunlametinib
Melanoma
Fudan UniversityP4BB (67)
DALPICICLIB ISETIONATE
Breast Cancer
Fudan UniversityP4BB (66)
Showing 1 to 25 of 637 assets
PreviousPage 1 of 26Next